B. Tirosh et al., THE EFFECT OF EUDRAGIT RL-100 ON THE MECHANICAL AND MUCOADHESION PROPERTIES OF POLYCARBOPHIL DOSAGE FORMS, Journal of controlled release, 45(1), 1997, pp. 57-64
Polycarbophil is a high molecular weight acrylic polymer which posses
enzymatic inhibition and absorption enhancement properties. However, i
ts use is limited because of poor mechanical properties. In this study
Eudragit(R) RL-100 was tested as a possible regulating agent for poly
carbophil solid formulations. Although swelling of polycarbophil-Eudra
git(R) RL-100 films was lower in PBS pH=5.0 than in PBS pH=7.4, in bot
h cases there was a profound difference between the swelling of pure p
olycarbophil films and films made of mixtures of polycarbophil and inc
reasing amounts of Eudragit(R) RL-100. Eudragit(R) RL-100 was able to
significantly decrease the swelling of polycarbophil films in a concen
tration-dependent manner. The incorporation of Eudragit(R) RL-100 into
polycarbophil also affected the mechanical properties of the films, a
s was evident from the torsion force and modulus of elasticity measure
ments. The higher the amount of Eudragit(R) RL-100 in the mixtures wit
h the polycarbophil, the larger the values of torsion force and modulu
s of elasticity. In the case of tablets made of different ratios of Eu
dragit(R) RL-100 and polycarbophil, the larger the amount of Eudragit(
R) RL-100 the higher the rate of erosion of the tablet. Tablets contai
ning predetermined ratios of polycarbophil and Eudragit(R) RL-100 were
able to synchronize the release rate of sodium cefazolin and ibuprofe
n. It was found that the similarity in the release rates resulted from
a controlled erosion process governed by balancing the ratio of Eudra
git(R) RL-100 and polycarbophil. The mucoadhesion properties of polyca
rbophil-Eudragit(R) RL-100 tablets with increasing amounts of Eudragit
(R) RL-100 was measured in different regions of the GI tract of the ra
t. It was found that tablets containing up to 20%w/w of Eudragit(R) RL
-100 adhered significantly better to the cecum of the rat and that the
ir adherence to the stomach, jejunum and colon did not differ from eac
h other. Eudragit(R) RL-100 concentrations of 50%w/w and above signifi
cantly reduced the ability of polycarbophil to adhere to the GI epithe
lium. Based on the reported findings it is suggested that solid dosage
forms made of mixtures of polycarbophil and Eudragit(R) RL-100 may be
suitable for the oral delivery of drugs, such as proteinaceous drugs,
susceptible to enzymatic degradation.